ELIVAX Trademark

Trademark Overview


On Wednesday, December 1, 2021, a trademark application was filed for ELIVAX with the United States Patent and Trademark Office. The USPTO has given the ELIVAX trademark a serial number of 97151094. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 24, 2023. This trademark is owned by Elixirgen Therapeutics, Inc.. The ELIVAX trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Vaccines for human use; vaccines for animals; pharmaceutical drugs for the treatment of cancer; vaccines for the treatment of cancer; vaccine adjuvants

Medical services, namely, inoculating people with vaccines; administering vaccines

Research and development of vaccines and medicines
elivax

General Information


Serial Number97151094
Word MarkELIVAX
Filing DateWednesday, December 1, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 24, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements


Goods and ServicesVaccines for human use; vaccines for animals; pharmaceutical drugs for the treatment of cancer; vaccines for the treatment of cancer; vaccine adjuvants
Goods and ServicesMedical services, namely, inoculating people with vaccines; administering vaccines
Goods and ServicesResearch and development of vaccines and medicines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 6, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 6, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameElixirgen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21205

Party NameElixirgen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21205

Trademark Events


Event DateEvent Description
Monday, July 24, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 24, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 20, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, September 20, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 20, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, September 20, 2022EXAMINERS AMENDMENT -WRITTEN
Saturday, September 10, 2022ASSIGNED TO EXAMINER
Monday, December 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 4, 2021NEW APPLICATION ENTERED